Literature DB >> 12046613

Recurrent crystal-storing histiocytosis of the lung in a patient without a clonal lymphoproliferative disorder.

D Jones1, A A Renshaw.   

Abstract

A 54-year-old woman developed an asymptomatic solitary lung mass, which recurred 10 years after resection. Both lesions consisted of a localized collection of intra-alveolar and interstitial macrophages filled with numerous eosinophilic cytoplasmic crystals. The crystals were non-birefringent, periodic acid-Schiff-negative, and showed polytypic reaction with both kappa and lambda light chains, and alpha, mu, and gamma heavy chains. No immunoglobulin gene rearrangements were detected. This lesion is consistent with crystal-storing histiocytosis, which has been reported in association with plasmacytoma. However, in this case, the absence of monotypic immunoglobulin staining within the crystals or the surrounding plasma cells, the absence of DNA rearrangements, and the long asymptomatic course raise the possibility that this lesion may be reactive. Similar lesions are seen in the lungs of mice with immune defects. Crystal-storing histiocytosis may represent a general reaction pattern to excess immunoglobulin.

Entities:  

Mesh:

Year:  1996        PMID: 12046613

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  3 in total

Review 1.  Crystal-storing histiocytosis associated with MALT lymphoma of the ocular adnexa: a case report with review of literature.

Authors:  Takashi Kusakabe; Kazuo Watanabe; Takafumi Mori; Tomohiro Iida; Toshimitsu Suzuki
Journal:  Virchows Arch       Date:  2006-11-17       Impact factor: 4.064

2.  Localized crystal-storing histiocytosis of the posterior fossa.

Authors:  Margaret E Flanagan; Christopher Dirk Keene; David N Louis; Gordana Juric-Sekhar
Journal:  Neuropathology       Date:  2018-07-31       Impact factor: 1.906

Review 3.  Immunoglobulin-Storing Histiocytosis: A Case Based Systemic Review.

Authors:  Hanne Wiese-Hansen; Friedemann Leh; Anette Lodvir Hemsing; Håkon Reikvam
Journal:  J Clin Med       Date:  2021-04-23       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.